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ABSTRACT 
 
Aim 
The findings reported in this paper explore the prescriptions issued to dermatology patients by 
Nurse Independent and Nurse Supplementary Prescribers.  
 
Methods 
Prescriptions were collected from 10 nurse prescribers. Each nurse formed the focus of a case 
study, which represented a setting within England in which nurses prescribed medicines for 
dermatology patients. Case studies were selected from a national survey of NIP/NSP and 
multiple methods of data collection were employed at each site. The nurse prescriber within  
each case study was asked to video-tape 5 of their consultations with dermatology patients. 
All prescriptions given to these patients were independently assessed. Data was collected 
between June 2006 and September 2007.  
 
Results 
Prescriptions were written on the correct documentation, were written legibly in ink, and 
provided the correct terminology. Specialist nurses were more likely than general practice 
nurses to provide clear and accurate instructions regarding the frequency, location, and 
application of topical therapies (p=0.02), hand write prescriptions, and prescribe by brand 
name. Nurses in general practice were more likely to computer generate prescriptions, 
prescribe generically (p=0.02), and provide information about the number of days treatments 
were required.  
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Conclusion 
Accurate complete prescriptions increase the likelihood that the treatment a patient receives 
will be successful. The prescriptions issued by nurses for dermatology patients are sometimes 
incomplete. Omissions differ between general practice and specialist nurses. Although these 
omissions are minor, and are not in themselves dangerous, they could lead to problems in 
other aspects of the medication process which could result in patient harm. It is important that 
mechanisms are in place, such as access to electronic prescribing, monitoring and audit of 
prescribing, to ensure the quality of prescriptions written by nurses. 
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INTRODUCTION 
Approximately 2.5 million prescriptions are written daily by doctors, 80% of which are 
written by General Practitioners (Department of Health (DoH) 2004). The increase in chronic 
diseases, new medicines, and advances in medicine generally, means that each year the 
volume of prescriptions in the United Kingdom (UK) continues to rise (National Patient 
Safety Agency (NPSA 2007). Drug use also increases with age, and approximately 80% of 
people aged over 75 use prescription medicines, 40 % of whom take four or more medicines 
each day (Medicines Partnership 2002).  
Recent National Health Service (NHS) reforms (DoH) 1999, DoH 2000), emphasize the need 
to provide services which are both flexible and accessible. Central to these reforms is the 
prescription of medicines. A number of different groups of healthcare professionals are now 
able to prescribe. As of 2006, appropriately qualified nurses and pharmacists have had 
virtually the same independent prescribing rights as doctors and are able to prescribe any 
licensed medicine and some controlled drugs (DoH 2006). These two groups of healthcare 
professionals are also able to prescribe any medicine as a supplementary prescriber i.e. in 
partnership with a doctor and provided that the medicine is listed on the patient’s Clinical 
Management Plan (CMP) (DoH 2003). In 2005, legislative changes enabled the prescription 
of medicine by optometrists, and allied health professionals (i.e. physiotherapists, 
radiographers, and podiatrists) under supplementary prescribing. Further changes to 
legislation in 2007 (DoH 2007), provided appropriately qualified optometrists with 
independent prescribing rights.   
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Most medicines are prescribed safely however, it is suggested that the direct costs from 
medication errors (ME) in NHS hospitals alone are £400-750 million per year (NPSA 2007). 
ME are recognised as any preventable event, that may cause or lead to inappropriate 
medication use, or patient harm, while the medication is in the control of the health 
professional, patient  or consumer (DoH 2004). Successful treatment  is contingent upon the 
comprehension of the pharmacist and/or nurse and patient on the instructions and dosage 
information written on the prescription (Beckman et al. 2005). Inadequate information given 
by the prescriber can result in errors. An accurate drug prescription may be defined as one 
which tries to maximize effectiveness, minimize risks, minimize costs and respect patient 
choice (Barber 1995). Accurate and clearly written prescriptions increases the likelihood that 
the treatment a patient receives will be successful (Winslow et al. 1997, NPSA 2007). As 
50% of medicines are not taken as intended, it is important that every attempt is made to 
ensure that prescriptions are written correctly (Medicines Partnership 2002).  This includes 
the full generic title of the medicine, the dose and frequency, the number of days treatment is 
required, and the quantity of medicine to be supplied, (British National Formulary (BNF) 
2008).   
 
Approximately 15% of the population see their General Practitioner for a skin condition each 
year (DoH 2007). Of the 14,000 nurses qualified to prescribe both as independent and 
supplementary prescribers, the majority work in general practice and over 70% of these 
nurses prescribe medicines for skin disease (Courtenay et al. 2006a). Given the high numbers 
of these ‘new prescribers’ who prescribe medicines for dermatology patients, it is important 
that the  prescriptions these nurses write are accurate and complete.      
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THE STUDY 
Aim 
The findings reported in this paper explore the prescriptions issued to dermatology patients by 
Nurse Independent Prescribers (NIPs) and Nurse Supplementary Prescribers (NSPs).  
 
METHODS 
Prescriptions were collected from 10 nurse prescribers. Each nurse formed the focus of a case 
study, which represented a setting within England in which nurses prescribed medicines for 
dermatology patients. Case studies were selected from a national survey of NIP/NSP. 
Multiple methods of data collection were employed at each case study site and included semi-
structured interviews with healthcare professionals, video-taped observations of nurse-patient 
consultations, and patient questionnaires. Findings from the national survey and data collected 
at case study sites addressed boarder study objectives and are reported elsewhere (Courtenay 
et al 2006a, Courtenay et al 2006b, Carey et al 2007, Courtenay et al 2007). The nurse 
prescriber at each case study site was asked to video-tape 5 of their consultations with 
dermatology patients. All prescriptions given to these patients were made anonymous, 
photocopied, and collected and independently assessed by a dermatology medical consultant 
and a dermatology nurse consultant using a prescription assessment form. Each assessor rated 
the various aspects of the prescription using ‘1’= Safe practice/accurate, ‘0’= Unsafe 
practice/omitted. Inter-rater reliability was enhanced by pilot work and discussion between 
the researchers and the 2 assessors about how to use the tool.  
 
 
 
 6
 
Participants  
Nurse prescribers at case study sites included Dermatology Specialist Nurses (DSNs) (n=4) 
and a Dermatology Nurse Consultant (DNC) (each of whom worked across both primary and 
secondary care), Practice Nurses (PNs) (n=3) (two practice nurses worked in one site) and  
Nurse Practitioners (NP) (n=2) (each of whom worked in primary care). Each nurse prescriber 
was well established in their role and had between 1-4 years experience as a prescriber.  
 
Reliability and Validity 
The prescription assessment form was developed from previous research (Britten et al. 2003) 
and the guidelines for prescription writing described in the British National Formulary (BNF) 
(British Medical Association (BMA) 2008). The form assessed prescriptions for accuracy, 
legibility, the use of correct terminology, whether medicines were prescribed generically, 
preparation details (i.e. strength if appropriate), dose, dose frequency, length of treatment and 
instructions regarding the frequency, location and application of topical treatments.  
 
Ethical approval 
The study was approved by the appropriate university and NHS research ethics and research 
governance committees.  
 
Data Analysis 
Microsoft Excel and SPSS version 14 were used for data entry and analysis. Descriptive 
statistics were used to describe the various aspects of the prescription. Chi-squared (X2) tests 
were used to investigate the relationship between the type of nurse and each aspect of the 
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prescription. Nurse types included specialist nurses (DSN & DNC) and general practice (GP) 
nurses (PN & NP).  
 
RESULTS 
Prescriptions 
Prescriptions written for 35 dermatology patients across the 10 case study sites were collected 
and assessed. Seventy nine medicines were prescribed i.e. fifty by specialist nurses and 29 by 
GP nurses. All prescriptions written by specialist nurses were hand written. All prescriptions 
written by GP nurses (apart from 1) were computer generated. GP nurses predominantly 
prescribed medicines for patients with minor skin conditions (e.g. fungal infections & 
impetigo) requiring preparations for topical application. By contrast, specialist nurses 
generally prescribed medicines for patients with chronic skin conditions (e.g. eczema, 
psoriasis & acne) requiring both topical and systemic treatments.   
 
Prescribing documentation and generic prescribing 
All prescriptions were written on the appropriate documentation i.e. on lilac NIP/NSP 
prescription pads, computer generated prescription, or, hospital prescription forms. Twenty 
seven items (77.1%) were prescribed generically (see Table 1) and eight (22.9%), were 
prescribed by their brand name. There was a difference between type of nurse and whether 
medicines were prescribed by their brand or generic title. Just over 65% of the items 
prescribed by specialist nurses were prescribed by their brand name and all items by GP 
nurses were prescribed generically. This difference was statistically significant (p=0.02) (see 
Table 2).  
 
Drug dosage and duration information 
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Information regarding drug dosage and duration is presented in Table 1. Over 77% of the 
items prescribed provided details of the strength of preparations and dosage. Only 34.3% 
provided information on dose frequency. Information on the number of days that treatments 
were required was evident in over 50% of the prescriptions. Just over 60% provided 
information on the quantity of medicine to be supplied.   
 
Instructions for patients 
Clear and accurate instructions regarding frequency, location and application of topical 
treatment were provided on 60% of prescriptions (see Table 1).   
 
Chi squared was used to analyse the relationship between the type of nurse and the provision 
of instructions. A greater number of specialist nurses as compared to practice nurses provided 
this information (p=0.02) (see Table 2). 
 
DISCUSSION 
This is only a small study, that examined the prescriptions of specialist and GP nurses (who 
worked predominantly in primary care), issued to dermatology patients. However, given that 
the Government has committed to reducing the incidents of medication errors in prescribed 
drugs by 40% (DoH 2004), and very little or no research has examined the prescriptions 
written by nurses, our study provides some useful information.    
 
It is evident from our findings that the prescriptions written by nurses for dermatology 
patients were reliably issued on an appropriate prescription form, and were written legibly in 
ink using the correct terminology. Nurses, however, were less consistent in other aspects of 
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prescription writing, a number of prescriptions being incomplete with regards to information 
on dose frequency, duration of treatment, and application instructions.   
 
It is evident from the prescription data collected that the types of information omitted from 
prescriptions varied between GP nurses and specialist nurses. Specialist nurses, as compared 
to GP nurses, were more likely to prescribe medicines using their brand name, provide 
information on the dose of the medicine, strength of preparations, and instructions on the use 
of the preparation. However, GP nurses were more likely to prescribe generically and provide 
details about the quantity of medicine to be supplied.  
 
The use of generic prescribing is encouraged. Generic titles are used in scientific publications, 
they indicate the class of medication (and so facilitate understanding of how medicines work), 
and are recognised internationally. However, some patients may develop intolerance to a 
particular ingredient in a generic medicine and this is a justified reason to change to a 
different product. Specialist nurses in this study generally prescribed longer term treatments 
for chronic skin conditions.  Some of these long-term treatment e.g. emollients, vary with 
regards to their constituents, to which in some instances, patients can become sensitive. To 
avoid this situation, it would be necessary for the prescriber to write the brand name of the 
product. Additionally, some patients on long-term treatments may never be reassured that a 
generic medicine is equivalent to their branded alternative, and generic equivalents may vary 
with regards to frequency of dose or application. In these situations it is more important that a 
patient takes their medicine and so prescribing a treatment by its brand name is justified.   It is 
also important that the patient receives the same preparation no matter which pharmacy they 
go to. This will be ensured by prescribing by the brand name. The above may explain the use 
of brand names on the prescriptions of specialist nurse prescribers.   
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Practitioners responsible for the management of long-term skin conditions have to help the 
patient manage their condition during a lifetime, reducing the severity of relapses, and 
extending the periods of remission. Information and advice represent the most important 
factors influencing the use of topical medication by these patients (Buchanan 2004). It is 
evident from our findings that specialist nurses were more likely to provide information on 
the dose of the medicine, strength of preparations, and instructions on the use of the 
preparation.  This can perhaps be accounted for by the level of knowledge of the specialist 
nurses in our study and the nature of the chronic conditions in which they were involved in 
treating. 
 
The lack of instructions provided by general practice nurses is concerning. Although it could 
be argued that as most of the patients who saw GP nurses did so for minor conditions, 
requiring one-off treatments, they may have required less detailed instructions about how to 
use their medicines. However, it is known that patients often forget a large proportion of what 
has been discussed during a consultation, and frequently rely on the instructions given on the 
label of the medicine (Beckman et al. 2005). It is therefore important that clear and accurate 
instructions about how to use the medicine are provided on the prescription.  
 
The general practice nurses in our study were more likely to computer generate prescriptions. 
Computer generated prescriptions prompt the prescriber to select a specific formulation, its 
dose and quantity. This could explain why the prescriptions of general practice nurses in our 
study were more likely to include information on the quantity of medicine to be supplied and 
the generic title. As the specialist nurses in our study worked across both primary and 
secondary care, but were hospital based, this finding reinforces the need for greater 
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availability of electronic prescribing in the hospital setting (DoH 2004).  This has the 
potential to improve the completeness of prescriptions issued by specialist nurses and so 
reduce the likelihood of error.  Access to new technologies such as electronic prescribing will 
also bring additional benefits such as links to prescribing information such as the BNF, alerts 
to allergies, bar-coding to help reduce patient identification errors, and electronic transmission 
to the pharmacy to speed up the dispensing process.  
. 
Study Limitations 
This is only a small study and therefore the results lack generalizability to other settings and 
therapeutic areas. Three nurse prescribers working in general practice, who saw dermatology 
patients in their minor illness clinics, found it difficult to record patient consultations and 
copy prescriptions as it was disruptive to their practice. Only 4 prescriptions were issued and 
assessed between these 3 nurses.  Nurses were aware that their prescriptions would be 
assessed; it is therefore possible that they were more conscious of the need to ensure that their 
prescriptions were complete. This may have influenced the prescriptions that were submitted 
for assessment. 
 
Conclusion 
Accurate complete prescriptions increase the likelihood that the treatment a patient receives 
will be successful. The prescriptions issued by nurses for dermatology patients are sometimes 
incomplete. Omissions differ between GP and specialist nurses. Although these omissions are 
minor, and are not in themselves dangerous, they could lead to problems in other aspects of 
the medication process which could result in patient harm. It is important that mechanisms are 
in place, such as access to electronic prescribing, monitoring and audit of prescribing, to 
ensure the quality of prescriptions written by nurses. 
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Key Points 
 Medication errors cost the National Health Service £400-750 million per year 
 16% of medication errors occur during the prescription of medicines 
 Accurate well written prescriptions  decrease medication errors and increase the 
likelihood that the treatment a patient receives will be successful 
 Nurses prescribing for dermatology patients use the correct documentation, write 
legibly in ink, and use the correct terminology. 
 Specialist nurses are more likely to hand write prescription, prescribe by brand name 
and provide clear and accurate instructions regarding the frequency, location, and 
application of topical therapies 
 Nurses in general practice are more likely to computer generate prescriptions, 
prescribe generically and provide information about the number of days treatments are 
required.    
 It is important that mechanisms are in place, such as access to electronic prescribing, 
monitoring and audit of prescribing practice, to ensure the quality of prescriptions 
written by nurses.  
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TABLE 1: Assessment of Prescriptions 
 
 
  YES NO 
 % n % n 
Dose frequency (in words) 
 
34.3 12 65.7 23 
Number of days treatment required 
 
54.3 19 45.7 16 
Clear & accurate instructions regarding  
frequency, location & application of topical 
treatment. 
60.0 21 40.0 14 
Quantity to be supplied (in brackets) 
 
62.8 22 37.1 13 
Accurate product information (i.e. strength) 
 
77.1 27 22.9 8 
Generic prescribing 
 
77.1 27 22.9 8 
Dose (in number) 
 
82.8 29 17.2 6 
Correct terminology 
 
100 35 0 0 
Written legibly in ink  
 
100 35 0 0 
Appropriate prescription documentation 
 
100 35 0 0 
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TABLE 2: Assessment of Prescriptions by type of nurse 
 
 
Specialist nurses= ‘dermatology specialist nurse’ and ‘dermatology nurse consultant’,  
GP nurses = ‘practice nurse’ and ‘nurse practitioner’ 
 
 
 
 
 
 
 
 
 
Specialist Nurses GP Nurses X2 test  
Yes No Yes No P value 
 % n % n % n % n  
Generic prescribing 
 
65.2 15 34.8 8 100 12 0 0 0.02 
Dose (in numbers) 
 
86.9 20 13.1 3 75.0 9 25.0 3 0.37 
Accurate product information (i.e. 
strength) 
82.6 19 17.4 4 75.0 9 25.0 3 0.59 
Quantity to be supplied (in 
brackets) 
 
52.2 12 47.8 11 83.3 10 16.7 2 0.07 
Clear & accurate instructions 
regarding  frequency, location & 
application of topical treatment  
 
78.2 18 21.8 5 25.0 3 75.0 9 0.02 
Number of days treatment required 
 
52.1 12 47.8 11 58.3 7 41.7 5 0.72 
Dose frequency (in words) 34.8 8 65.2 15 33.3 4 66.7 8 0.93 
